These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 30803124)
1. Circulating ceruloplasmin, ceruloplasmin-associated genes and the incidence of venous thromboembolism in the Atherosclerosis Risk in Communities study. Arenas de Larriva AP; Alonso A; Norby FL; Roetker NS; Folsom AR J Thromb Haemost; 2019 May; 17(5):818-826. PubMed ID: 30803124 [TBL] [Abstract][Full Text] [Related]
2. Circulating ceruloplasmin, ceruloplasmin-associated genes, and the incidence of atrial fibrillation in the atherosclerosis risk in communities study. Arenas de Larriva AP; Norby FL; Chen LY; Soliman EZ; Hoogeveen RC; Arking DE; Loehr LR; Alonso A Int J Cardiol; 2017 Aug; 241():223-228. PubMed ID: 28427851 [TBL] [Abstract][Full Text] [Related]
3. Ceruloplasmin and heart failure in the Atherosclerosis Risk in Communities study. Dadu RT; Dodge R; Nambi V; Virani SS; Hoogeveen RC; Smith NL; Chen F; Pankow JS; Guild C; Tang WH; Boerwinkle E; Hazen SL; Ballantyne CM Circ Heart Fail; 2013 Sep; 6(5):936-43. PubMed ID: 23861484 [TBL] [Abstract][Full Text] [Related]
4. Prospective study of circulating factor XI and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE). Folsom AR; Tang W; Roetker NS; Heckbert SR; Cushman M; Pankow JS Am J Hematol; 2015 Nov; 90(11):1047-51. PubMed ID: 26260105 [TBL] [Abstract][Full Text] [Related]
5. Atrial fibrillation and venous thromboembolism: evidence of bidirectionality in the Atherosclerosis Risk in Communities Study. Lutsey PL; Norby FL; Alonso A; Cushman M; Chen LY; Michos ED; Folsom AR J Thromb Haemost; 2018 Apr; 16(4):670-679. PubMed ID: 29431904 [TBL] [Abstract][Full Text] [Related]
6. Replication of a genetic risk score for venous thromboembolism in whites but not in African Americans. Folsom AR; Tang W; Weng LC; Roetker NS; Cushman M; Basu S; Pankow JS J Thromb Haemost; 2016 Jan; 14(1):83-8. PubMed ID: 26565658 [TBL] [Abstract][Full Text] [Related]
7. Clinical and genetic association of serum ceruloplasmin with cardiovascular risk. Tang WH; Wu Y; Hartiala J; Fan Y; Stewart AF; Roberts R; McPherson R; Fox PL; Allayee H; Hazen SL Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):516-22. PubMed ID: 22075249 [TBL] [Abstract][Full Text] [Related]
8. Lung function, respiratory symptoms and venous thromboembolism risk: the Atherosclerosis Risk in Communities Study. Kubota Y; London SJ; Cushman M; Chamberlain AM; Rosamond WD; Heckbert SR; Zakai N; Folsom AR J Thromb Haemost; 2016 Dec; 14(12):2394-2401. PubMed ID: 27696765 [TBL] [Abstract][Full Text] [Related]
9. Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study. Kubota Y; McAdams-DeMarco M; Folsom AR Thromb Res; 2016 Aug; 144():144-8. PubMed ID: 27337701 [TBL] [Abstract][Full Text] [Related]
10. Racial and regional differences in venous thromboembolism in the United States in 3 cohorts. Zakai NA; McClure LA; Judd SE; Safford MM; Folsom AR; Lutsey PL; Cushman M Circulation; 2014 Apr; 129(14):1502-9. PubMed ID: 24508826 [TBL] [Abstract][Full Text] [Related]